Brief: PHERECYDES Pharma Strengthens Its Corporate Links With ERYTECH To Prepare Strategic Combination
16/05/2023 06:33
May 16 (Reuters) - Pherecydes Pharma SA ALPHE.PA :
* PHERECYDES STRENGTHENS ITS CORPORATE LINKS WITH ERYTECH TO
PREPARE THE STRATEGIC COMBINATION
* ENTRY INTO A DEFINITIVE MERGER AGREEMENT BETWEEN
PHERECYDES AND
ERYTECH
* COMBINATION WITH ERYTECH TO BE SUBMITTED TO SHAREHOLDERS'
VOTE
ON JUNE 23, 2023
* PROPOSED MERGER IS EXPECTED TO CLOSE SHORTLY AFTER
APPROVAL BY
BOTH PHERECYDES AND ERYTECH SHAREHOLDERS.
Source text for Eikon: ID:nBw57yCwJa
Further company coverage: ALPHE.PA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Pherecydes Pharma SA
See all newsBrief: Erytech And Pherecydes Announce Merger And Name Change To Phaxiam Therapeutics
Brief: Pherecydes Pharma SA - Pherecydes Pharma And Erytech Pharma Shareholders Approve Merger Between Two Companies To Create Phaxiam Therapeutics
Brief: Erytech Announces That The Commercial Court Has Rejected Akkadian's Request To Postpone The Vote On The Merger With Pherecydes Pharma
Brief: Erytech: urges shareholders to vote for merger with Pherecydes and dismisses Akkadian's moves
Brief: Erytech Pharma Says Akkadian Has Initiated Proceedings To Postpone Vote On Merger With Pherecydes